Autonomix Medical accepts two abstracts for CIRSE 2026 poster
Autonomix Medical announced acceptance of two abstracts for poster presentation at CIRSE 2026. The abstracts highlight potential of the company’s transvascular technology across pain management and nervous system mapping.
Abstracts highlight potential of Autonomix’s transvascular technology across pain management and nervous system mappingTHE WOODLANDS, TX, Sept.
01, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.
NASDAQ:AMIX (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision…